1. Home
  2. LRHC vs ACON Comparison

LRHC vs ACON Comparison

Compare LRHC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRHC
  • ACON
  • Stock Information
  • Founded
  • LRHC 2004
  • ACON 2008
  • Country
  • LRHC United States
  • ACON United States
  • Employees
  • LRHC N/A
  • ACON N/A
  • Industry
  • LRHC
  • ACON Retail: Computer Software & Peripheral Equipment
  • Sector
  • LRHC
  • ACON Technology
  • Exchange
  • LRHC Nasdaq
  • ACON Nasdaq
  • Market Cap
  • LRHC 5.6M
  • ACON 4.5M
  • IPO Year
  • LRHC 2023
  • ACON 2022
  • Fundamental
  • Price
  • LRHC $4.87
  • ACON $7.67
  • Analyst Decision
  • LRHC
  • ACON Buy
  • Analyst Count
  • LRHC 0
  • ACON 2
  • Target Price
  • LRHC N/A
  • ACON $481.00
  • AVG Volume (30 Days)
  • LRHC 404.8K
  • ACON 14.2K
  • Earning Date
  • LRHC 08-18-2025
  • ACON 08-13-2025
  • Dividend Yield
  • LRHC N/A
  • ACON N/A
  • EPS Growth
  • LRHC N/A
  • ACON N/A
  • EPS
  • LRHC N/A
  • ACON N/A
  • Revenue
  • LRHC $73,874,281.00
  • ACON $54,601.00
  • Revenue This Year
  • LRHC N/A
  • ACON $145.39
  • Revenue Next Year
  • LRHC N/A
  • ACON $145.45
  • P/E Ratio
  • LRHC N/A
  • ACON N/A
  • Revenue Growth
  • LRHC 90.36
  • ACON N/A
  • 52 Week Low
  • LRHC $4.33
  • ACON $6.20
  • 52 Week High
  • LRHC $142.40
  • ACON $3,499.51
  • Technical
  • Relative Strength Index (RSI)
  • LRHC 35.19
  • ACON 46.65
  • Support Level
  • LRHC $4.33
  • ACON $6.51
  • Resistance Level
  • LRHC $5.49
  • ACON $7.42
  • Average True Range (ATR)
  • LRHC 0.72
  • ACON 0.41
  • MACD
  • LRHC -0.15
  • ACON -0.01
  • Stochastic Oscillator
  • LRHC 18.09
  • ACON 46.68

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: